Search research articles
Contact Us
Filters
Showing results (141-150 of 182) with videos related to
Page
of 19
Sort By:
Cytokine
|
May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infection
Vincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Cell Death & Disease
|
October 30, 2021
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients
Andrea Sacconi, Claudia De Vitis, Luisa de Latouliere, et al.
Science Advances
|
August 19, 2021
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection
Nader Yatim, Jeremy Boussier, Pauline Tetu, et al.
Journal of Clinical Immunology
|
June 24, 2020
Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome
Xiao-Fei Kong, Lisa Worley, Darawan Rinchai, et al.
Nature Immunology
|
May 5, 2018
Publisher Correction: Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
Etienne Patin, Milena Hasan, Jacob Bergstedt, et al.
Nature Immunology
|
February 25, 2018
Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
Etienne Patin, Milena Hasan, Jacob Bergstedt, et al.
The Journal of Clinical Investigation
|
January 4, 2021
TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons
Daxing Gao, Michael J Ciancanelli, Peng Zhang, et al.
Journal of Clinical Immunology
|
August 28, 2024
Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System Inflammation
Clément Triaille, Neha Mohan Rao, Gillian I Rice, et al.
Nature
|
September 4, 2024
Immune system adaptation during gender-affirming testosterone treatment
Tadepally Lakshmikanth, Camila Consiglio, Fabian Sardh, et al.
Science (New York, N.Y.)
|
July 15, 2020
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jérôme Hadjadj, Nader Yatim, Laura Barnabei, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 182) with videos related to
Sort By:
Page
of 19
Cytokine
|
May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infection
Vincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Cell Death & Disease
|
October 30, 2021
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients
Andrea Sacconi, Claudia De Vitis, Luisa de Latouliere, et al.
Science Advances
|
August 19, 2021
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection
Nader Yatim, Jeremy Boussier, Pauline Tetu, et al.
Journal of Clinical Immunology
|
June 24, 2020
Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome
Xiao-Fei Kong, Lisa Worley, Darawan Rinchai, et al.
Nature Immunology
|
May 5, 2018
Publisher Correction: Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
Etienne Patin, Milena Hasan, Jacob Bergstedt, et al.
Nature Immunology
|
February 25, 2018
Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
Etienne Patin, Milena Hasan, Jacob Bergstedt, et al.
The Journal of Clinical Investigation
|
January 4, 2021
TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons
Daxing Gao, Michael J Ciancanelli, Peng Zhang, et al.
Journal of Clinical Immunology
|
August 28, 2024
Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System Inflammation
Clément Triaille, Neha Mohan Rao, Gillian I Rice, et al.
Nature
|
September 4, 2024
Immune system adaptation during gender-affirming testosterone treatment
Tadepally Lakshmikanth, Camila Consiglio, Fabian Sardh, et al.
Science (New York, N.Y.)
|
July 15, 2020
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jérôme Hadjadj, Nader Yatim, Laura Barnabei, et al.
Page
of 19